Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy

Cancer stem cells (CSCs) are the main drivers of disease progression and chemotherapy resistance in breast cancer. Tumor progression and chemoresistance might then be prevented by CSC-targeted therapies. We previously demonstrated that Toll-like Receptor (TLR)2 is overexpressed in CSCs and fuels the...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Lorenzo, Antonino, Bolli, Elisabetta, Ruiu, Roberto, Ferrauto, Giuseppe, Di Gregorio, Enza, Avalle, Lidia, Savino, Aurora, Poggio, Pietro, Merighi, Irene Fiore, Riccardo, Federica, Brancaccio, Mara, Quaglino, Elena, Cavallo, Federica, Conti, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225225/
https://www.ncbi.nlm.nih.gov/pubmed/35756841
http://dx.doi.org/10.1080/2162402X.2022.2086752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225225/
https://www.ncbi.nlm.nih.gov/pubmed/35756841
http://dx.doi.org/10.1080/2162402X.2022.2086752

Ejemplares similares